Clinical Trial

If you’ve recently been diagnosed with bladder cancer and are scheduled for a tumor-removal surgery (TURBT), you may qualify for this pioneering study. We’re testing whether combining surgery with an experimental non-chemotherapy drug designed to target and kill bladder cancer cells, can lower recurrence rates. This treatment has shown promise in earlier trials.

We’re now conducting a larger trial to seek FDA approval and are recruiting participants who can travel to our study center in Bakersfield, California. Interested? Answer the questions below to see if you qualify.

Note: To qualify you must join the study before tumor removal surgery or no more than 3 months after.

Watch this video to see how it works: